Skip to content

Pulse Biosciences, Inc. PLSE Q4 2024 Annual earnings

Reported March 27, 2025 · After market close

Revenue$1.7M
EPS-$0.17Beat by $0.07
EPS estimate-$0.24

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$533.3K
EPS estimate-$0.31

Financials

Q4 2024

Income statement

See full
Revenue-
Gross profit-
Operating income-$20.3M-61.7%
Net income-$19.4M-62.4%

Balance sheet

See full
Cash & equivalents$118.0M+166%
Total debt$8.9M-2.7%
Total equity$114.9M+159%
Total assets$132.5M+124%

Cash flow

See full
Operating cash flow-$9.1M-34.8%
CapEx$53.0K+23.3%
Free cash flow-$9.2M-34.8%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.07B+58.9%
Enterprise value$961.87M+50.6%

Returns & leverage

See full
Return on equity-67.3%
Debt / equity0.1×-0.1×
Current ratio11.9×+5.1×

Versus estimates

Ask the moment Pulse Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pulse Biosciences, Inc. report Q4 2024 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q4 2024 earnings on March 27, 2025 after market close.
What were Pulse Biosciences, Inc.'s Q4 2024 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of $1.7M and eps of $-0.17 for Q4 2024.
Did Pulse Biosciences, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.24 by $0.07.
Where can I find Pulse Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001437749-25-009932) directly on SEC EDGAR. The filing index links above go to sec.gov.